Risk stratification in the clinical application of minimal residual disease assessment in acute myeloid leukemia.
Zhang C, Gu R, Wang H, Zhou C, Li Y, Liu Y, Wei S, Lin D, Liu K, Fang Q, Gong X, Gong B, Qiu S, Zhang G, Liu B, Wang Y, Mi Y, Wei H, Wang J.
Zhang C, et al. Among authors: li y.
Cancer. 2025 Jan 1;131(1):e35641. doi: 10.1002/cncr.35641. Epub 2024 Nov 10.
Cancer. 2025.
PMID: 39522053